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The role of the transcriptional cyclin-
dependent kinase CDK11 in HIV
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to phosphorylate RNAPII and promote
assembly of cleavage and
polyadenylation factors at the HIV 30 end,
which ensures optimal HIV gene
expression.
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Transcriptional cyclin-dependent kinases play
important roles in eukaryotic gene expression.
CDK7, CDK9 (P-TEFb), and CDK13 are also critical
for HIV replication. However, the function of CDK11
remained enigmatic. In this report, we determined
that CDK11 regulates the cleavage and polyadenyla-
tion (CPA) of all viral transcripts. CDK11 was found
associated with the TREX/THOC, which recruited
this kinase to DNA. Once at the viral genome,
CDK11 phosphorylated serines at position 2 in the
CTD of RNAPII, which increased levels of CPA fac-
tors at the HIV 30 end. In its absence, cleavage of viral
transcripts was greatly attenuated. In contrast,
higher levels of CDK11 increased the length of HIV
poly(A) tails and the stability of mature viral tran-
scripts. We conclude that CDK11 plays a critical
role for the cotranscriptional processing of all HIV
mRNA species.
INTRODUCTION
The human immunodeficiency virus (HIV) is a retrovirus of the
lentivirus family that integrates into the host genome, where it be-
haves similarly to other human genes. Its transcription and repli-
cation have been studied extensively, and lessons learned from
HIV have contributed greatly to the understanding of eukaryotic
biology (Peterlin and Price, 2006). For example, studies of its
transcriptional transactivator (Tat) revealed that the control of
RNA polymerase II (RNAPII) elongation is an important step
in gene expression (Kao et al., 1987). It is now known that
most if not all genes have RNAPII already engaged at their
promoters and that extracellular cues can release it, thereby pro-
moting diverse cellular processes, which include activation,
proliferation, differentiation, and reprogramming (Rahl et al.,
2010). Further steps in cotranscriptional processing, 50 capping,
mRNA splicing, and 30 end formation, which include cleavage
and polyadenylation (CPA), have also profited greatly from
studies of HIV (Karn and Stoltzfus, 2012; Valente et al., 2009).
Importantly, all these events involve RNAPII, especially its C-ter-
minal domain (CTD). It contains 52 heptapeptide repeats560 Cell Host & Microbe 18, 560–570, November 11, 2015 ª2015 Els(YSPTSPS), which contain five residues that can be phosphory-
lated by various kinases for specific functions (Adelman and Lis,
2012).
In association with their respective cyclins (Cycs), transcrip-
tional cyclin-dependent kinases (CDKs) phosphorylate different
serines (Ser2P, Ser5P, or Ser7P) and the threonine (Thr4P) in
the CTD (Drogat et al., 2012; Loyer et al., 2005). These modifica-
tions play critical roles for 50 capping, mRNA splicing, andCPA of
primary transcripts (Blazek et al., 2011; Drogat et al., 2012; Loyer
et al., 2005). Indeed, differentially phosphorylated forms of
RNAPII provide binding platforms for complexes that execute
these early and late events in transcription. They ensure that
nascent RNA species mature into functional mRNAs, which
can be exported into the cytoplasm for translation (Huang and
Carmichael, 1996; Mu¨ller-McNicoll and Neugebauer, 2013;
Proudfoot, 2011; Wahle and Ru¨egsegger, 1999).
For HIV, the involvement of CDK7, CDK9, CDK11, and CDK13
has been documented. Tat potentiates the role of CycH:CDK7 in
50 capping of all viral transcripts (Zhou et al., 2003). Tat also re-
cruits its coactivator, CycT1:CDK9, which forms the positive
transcription elongation factor b (P-TEFb), for the transition
from initiation to elongation of HIV transcription (Peterlin and
Price, 2006). P-TEFb exists in two states, the active free form
and the inactive 7SK snRNP, from which it must be released to
target the HIV long terminal repeat (LTR) (Peterlin and Price,
2006). CycK:CDK13 affects mRNA splicing so that the overex-
pression and depletion of CDK13 decreases and increases the
production of HIV Gag and Env proteins and the production of
new viral particles, respectively (Berro et al., 2008). The role of
CycL:CDK11 is less well defined, especially since the depletion
and overexpression of CDK11 decreased levels of HIV replica-
tion, albeit in greatly different contexts (Valente et al., 2009; Yu
et al., 2008).
The transcription/export (TREX) complex connects transcrip-
tion and cotranscriptional processes. In yeast, TREX couples
transcription, mRNA processing, and mRNA nuclear export
(Stra¨sser et al., 2002). Suppressors of the transcriptional defects
of Hpr1D by overexpression complex (THOC) is required for tran-
scription elongation (Li et al., 2005; Rehwinkel et al., 2004). THO
proteins are also found in the TREX complex, hence the name
TREX/THOC (Masuda et al., 2005). TREX is found at the coding
and 30 ends of genes (Kim et al., 2004; Stra¨sser et al., 2002).
In addition to RNAPII and TREX/THOC, the human 30 end pro-
cessing complex contains cleavage and polyadenylation speci-
ficity factors (CPSFs), cleavage-stimulatory factors (CstFs), theevier Inc.
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Figure 1. CDK11 Associates with TREX/
THOC in 293 T Cells
(A) A schematic representation of CDK11 and
CycL2. CDK11 contains 782 residues and migrates
with an apparent molecular mass of 110 kDa. CycL2
contains 520 residues with an apparent molecular
mass of 58 kDa. White ovals depict regions rich in
glutamic acids (pE), the kinase domain of CDK11,
cyclin boxes, and the arginine-serine (RS)-rich
domain in CycL2.
(B) Dendrogram of the CDK11 proteome. Mass
spectrometry of proteins that coimmunoprecipi-
tated with CDK11 identified TREX/THOC (blue cir-
cles), EJC (orange circles), and various OTHER
(yellow circles) proteins.
(C) Coimmunoprecipitations of f:CDK11-interacting
proteins. Immunoprecipitation of FLAG epitope-
tagged CDK11 protein (f:CDK11) was followed by
western blotting with anti-FLAG, UAP56, THOC1,
CycL2, RBM8A, SAP18, and SCAMP2 antibodies.
Lanes contain the following: lane 1, input; lane 2,
coimmunoprecipitated proteins; lane 3, IgG control.
(D) Coimmunoprecipitations between endogenous
proteins. Immunoprecipitation of the endogenous
CDK11 protein (CDK11) was followed by western
blotting with anti-UAP56, THOC5, THOC1, and
RBM8A antibodies (lanes 3–7). Lanes are as in (C).poly(A) polymerase (PAP), and more than 50 other proteins (Shi
and Manley, 2015). Indeed, the depletion of THOC5 from the
TREX/THOC inhibited the expression of polyadenylated mRNA
species (Katahira et al., 2013). However, themechanism of these
effects remained unknown.
In this study, we were able to address these conundra. First,
we found that CDK11 binds to subunits of TREX/THOC, which
we validated structurally and functionally. In addition, levels of
CDK11 greatly affected HIV gene expression and replication.
We also demonstrated that CDK11 is recruited to the HIV
genome via TREX/THOC, where it increased levels of Ser2P
and the assembly of 30 end processing machinery. In cells
depleted of CDK11, HIV replicated poorly, the CPA machinery
was not recruited to the RNAPII, and HIV transcripts were not
cleaved or polyadenylated. In cells that overexpressed CDK11,
just the opposite was observed, which led to longer poly(A) tails
and greater stability of all HIV transcripts. We conclude that
CDK11mediates effects of TREX/THOC on transcription via crit-
ical modifications of RNAPII.
RESULTS
CDK11 Associates with TREX/THOC in 293T Cells
Humans have two genes, CDC2L1 and CDC2L2, which encode
multiple isoforms of CDK11/PITSLRE. CDK11, referred as a
p110 (110 kDa), is ubiquitously expressed in cells, and its p58
(58 kDa) isoform is specific for the G2/M phase (Loyer et al.,
2008). Another isoform, p46, is generated by caspase cleavage
of larger precursors and promotes apoptosis in human cells (Mi-
kolajczyk and Nelson, 2004). A tandem affinity purification (TAP)
in yeast also identified Cyclin L as the partner for CDK11 (Drogat
et al., 2012). Another integrative analysis of 3290 affinity-purifiedCell Host &proteins found CDK11 within the complex-complex interaction
network (CCI), which are type II coregulators that do not have
consistent steady-state stoichiometric partners (Malovannaya
et al., 2011).
In this study, we examined the long form of CDK11 (p110),
which displays extensive homology to other CDKs in its C-termi-
nal catalytic domain (Figure 1A, top). Its N terminus contains
many glutamic acid residues (poly[E], pE), which are encoded
by an RNA that also serves as an internal ribosome entry site
(IRES) (Loyer et al., 2005). CycL2 is the cyclin partner of
CDK11 (Figure 1A, bottom). It contains two cyclin boxes near
its N terminus and an arginine/serine-rich domain (RS domain)
near its C terminus. The RS domain is a hallmark of many pro-
teins involved in pre-mRNA processing (Figure 1A) (Loyer
et al., 2005). To identify potential CDK11-binding partners, we
used affinity purification and mass spectrometry (Ja¨ger et al.,
2012). After confirming the expression of FLAG epitope-tagged
CDK11 (f:CDK11) protein by western blotting, samples were pro-
cessed further. We identified 23 proteins from f:CDK11 mass
spectrometry using CompPASS (Sowa et al., 2009) and MiST
quantitative scoring systems (Ja¨ger et al., 2012; Verschueren
et al., 2015). Next, we organized proteins associated with
CDK11 into functional categories (Figure 1B). Most associated
peptides were from subunits of TREX/THOC. Also included
were members of the exon junction complex (EJC) and other
proteins, some of which bind to RNA (OTHER) (Figure 1B). In
agreement with previous reports, casein kinase II (CK2) and
CycL2 were present in our immunoprecipitations (de Graaf
et al., 2004; Dickinson et al., 2002; Trembley et al., 2003). Further
sequential f:CDK11 immunoprecipitations confirmed the binding
between CDK11, CycL2 and subunits of TREX/THOC (Fig-
ure 1C). In contrast, RBM8A, SAP18, and SCAMP2 did notMicrobe 18, 560–570, November 11, 2015 ª2015 Elsevier Inc. 561
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Figure 2. CDK11 Increases HIV Gene Expression and Replication in 293 T Cells
(A) Schematic representation of NL4-3.Luc and LTR.Luc plasmid targets, respectively. NL4-3.Luc does not express Env (crossed lines) and contains the
luciferase gene in the place of Nef.
(B) CDK11 activates NL4-3.luc and LTR.Luc. Luciferase activity wasmeasured in lysates of cells coexpressing f:CDK11 or the empty plasmid vector and LTR.Luc
or pNL4-3.Luc. Error bars represent mean ± SE, n = 3. Western blots of f:CDK11 and actin as the loading control are presented below the bar graph. See also
Figures S1 and S2.
(C) CDK11 increases the production of new viral particles. Presented is the HIV p24 ELISA of supernatants from cells that coexpressed f:CDK11 and NL4-3.Luc.
Error bars are as in (B).
(D) CDK11 increases the production of HIV structural proteins. Presented is awestern blot of HIVGag levels in cells expressing f:CDK11 andNL4-3.Luc or plasmid
vector control. Amounts of plasmid effectors are presented above the western blot. Lanes 1 and 4, lanes 2 and 5, and lanes 3 and 6 should be compared. Below
this panel are western blots of f:CDK11 and actin, as in (C).interact with f:CDK11 (Figure 1C). Coimmunoprecipitations with
the endogenous CDK11 protein confirmed these associations
(Figure 1D). Thus, CycL2:CDK11 bind to TREX/THOC in cells.
CDK11 Increases HIV Gene Expression and Replication
in 293T and Jurkat Cells
HIV gene expression requires cellular transcription factors (TFs),
where the role of CDK11 remained enigmatic (Valente et al.,
2009; Yu et al., 2008). To investigate the function of CDK11 in
HIV transcription, f:CDK11 effector and NL4-3.Luc or LTR.Luc
plasmid targets (Figure 2A) were coexpressed transiently in
293T (Figures 2B–2D) and Jurkat (see Figure S1 available online)
cells. Plasmid targets contained the luciferase reporter gene,
which enables a precise quantification of small changes in tran-
scription. Note that the NL4-3.Luc contained the luciferase re-
porter gene in place of Nef, which must undergo multiple
mRNA splicing events for expression. Additionally, the plasmid
target lacked the Env gene so that it did not infect other cells.
For control purposes, the empty pcDNA3.1 plasmid vector was
also coexpressed with these plasmid targets. Cells were lysed562 Cell Host & Microbe 18, 560–570, November 11, 2015 ª2015 Els48 hr after the transfection, and luciferase activity was
measured. Cells expressing f:CDK11 and NL4-3.Luc or LTR.Luc
exhibited 13- and 17-fold increased levels of luciferase, respec-
tively, compared to those with pcDNA3.1 alone (Figure 2B, bars
1–4). Since both plasmid targets had very similar responses, this
finding excludes increased mRNA splicing of NL4-3.Luc tran-
scripts. To confirm that CDK11 increases HIV replication, we
also collected supernatants from transfected 293T cells in tripli-
cate. As presented in Figure 2C, levels of p24 (Gag) were also
increased 22-fold in supernatants of cells that coexpressed
f:CDK11 and NL4-3.Luc. This increase in viral proteins was
confirmed by western blotting (Figure 2D). Next, f:CDK11 was
coexpressed with increasing amounts of NL4-3.Luc. After
48 hr, cells were lysed and submitted to western blotting with
anti-p24, FLAG, or actin antibodies. Levels of HIV p55, p44,
and p24 (Gag proteins) increased at least 10-fold in cells ex-
pressing f:CDK11 compared to controls (Figure 2D, compare
lanes 1 and 4, lanes 2 and 5, and lanes 3 and 6). Since
f:CDK11 affected all HIV plasmid targets, we also examined its
effects on several host cell and other viral promoters in Jurkatevier Inc.
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Figure 3. CDK11 Regulates Levels of all HIV
Transcripts in 293T Cells
(A) Schematic representation of HIV transcripts. The
three main viral mRNA species are represented: un-
spliced (US), singly spliced (SS), and multiply spliced
(MS) HIV transcripts. Arrows indicate the direction and
location of primers.
(B) CDK11 increases levels of all HIV transcripts. RT-
qPCR of HIV RNA from cells that coexpressed
f:CDK11 or plasmid vector and pNL4-3.Luc. Primers
were designed to detect unspliced (US) genomic,
singly spliced (SS), and multiply spliced (MS) HIV
transcripts. Error bars represent mean ± SE, n = 3.
(C) CDK11 depletion decreases HIV mRNA splicing.
CDK11-depleted cells coexpressed the same plas-
mids as in (B). Presented are RT-qPCR data with errors
as in (B). Western blots of CDK11 and actin are pre-
sented below the bar graph. See also Figure S3.cells (Figure S1). In all these cases, f:CDK11 increased their ac-
tivities from 7- to 30-fold (Figure S1). Thus, as was the case with
P-TEFb, CDK11 does not only activate HIV but also affects other
eukaryotic transcription units.
To validate our proteomic data, we also knocked down pro-
teins from Figure 1 via short interfering RNA (siRNA) in the pres-
ence and absence of f:CDK11. All interacting proteins were
subjected to RNAi screening. We found that the depletion of
THOC1 or THOC5 inhibited effects of f:CDK11 (Figures S2A
and S2B). Depletion of a subunit of the EJC (eIF4A3) and CK2
had no effect (Figures S2C and S2D). Knockdowns (KDs) were
confirmed by western blotting (Figure S2, panels below the bar
graphs). We conclude that CycL2:CDK11 interacts with subunits
of TREX/THOC structurally and functionally. Importantly, this
new complex plays a critical role in HIV gene expression and
replication.
CDK11 Regulates Levels of All HIV Transcripts in 293T
and Jurkat Cells
HIV transcripts undergo a series of mRNA splicing events that
generate singly spliced (SS) 4 kb mRNA species that code for
Env, Vpr, Vpu, and Vif and multiply spliced (MS) 2 kb mRNA spe-
cies that code for Tat, Rev, and Nef. The unspliced (US) 9 kb
mRNA codes for Gag and Gag/Pol polyproteins that form new
viral particles (Figure 3A). Balanced splicing of the viral mRNA
is critical for HIV replication and infectivity (Ocwieja et al.,
2012; Purcell andMartin, 1993). Primers for reverse transcription
quantitative polymerase chain reactions (RT-qPCR) (Figure 3A,
arrows below HIV RNA species) were designed to detect
differentmRNA species (Jablonski andCaputi, 2009). RT-qPCRs
revealed that all three different viral transcripts increased 6- to
10-fold in f:CDK11-expressing 293T cells (Figure 3B, bars 1–4).
These data confirm the increased expression of viral particlesCell Host & Microbe 18, 560–57and proteins observed in Figures 2C and
2D, respectively. In addition, the knockdown
of CDK11 decreased US, SS, and MS
transcripts in 293T cells (Figure 3C, bars
1–4). Whereas US transcripts were reduced
2-fold, those for spliced transcripts de-
creased 5-fold (Figure 3C, bars 2–4). Theratio of spliced to US transcripts was thus reduced 2- to
3-fold. A similar effect on mRNA splicing was also observed
in Jurkat cells (Figure S3). This finding agrees with other
reports on effects of CDK11 depletion on mRNA splicing (Loyer
et al., 2005). We conclude that CDK11 affects directly all HIV
transcripts.
CK2 Does Not Contribute to CTD Phosphorylation by
CDK11
It was reported previously that CK2 phosphorylates CDK11 and
the CTD (Trembley et al., 2003). To determine if CDK11 can also
phosphorylate the CTD of RNAPII independently of CK2, we per-
formed in vitro kinase assays with CDK11 in the presence and
absence of CK2 and the CTD of RNAPII. CK2was depleted using
siCK2 RNA. f:CDK11 was immunoprecipitated from wild-type
(WT) and CK2-depleted 293T cells and combined with the gluta-
thione S-transferase (GST)-CTD chimera, which was purified
from E. coli (Peterson et al., 1992). Kinase reactions were per-
formed in the presence of cold ATP. Residues in the CTD that
were phosphorylated were detected with anti-Ser2P and
Ser5P antibodies by western blotting (Czudnochowski et al.,
2012). Importantly, CDK11 phosphorylated serines at positions
2 and 5 in the CTD independently of CK2 (Figure 4, lanes 2
and 3). This result extends our finding that CK2 depletion did
not affect the increased HIV gene expression by f:CDK11 (Fig-
ure S2D). These data also suggest that CDK11 is a bona fide
CTD kinase.
CDK11 Depletion Decreases Levels of Ser2P, CstF77,
and PAP at the HIV Gene in HeLa P4 Cells
RNAPII synthesized transcripts undergo extensive processing
before they are transported to the cytoplasm, and the CTD di-
rects much of this activity (Barilla` et al., 2001; McCracken0, November 11, 2015 ª2015 Elsevier Inc. 563
Figure 4. CK2 Does Not Contribute to CTD Phosphorylation by
CDK11
Kinase assays were performed with the immunoprecipitated f:CDK11 protein
and GST-CTD using cold ATP, followed by western blotting with anti-Ser2P
and Ser5P antibodies. Lane 3 contains reactions with the immunoprecipitated
f:CDK11 protein from CK2-depleted cells. The western blot for the depletion of
CK2 is presented at the bottom.et al., 1997). Whereas Ser5P plays a critical role in 50 capping,
increased levels of Ser2P during transcription recruit splicing
and CPA complexes to RNAPII (Gu et al., 2013). We used chro-
matin immunoprecipitations (ChIPs) to investigate the effects of
CDK11 and TREX/THOC on levels of RNAPII, Ser2P, and Ser5P
and the 30 end formation machinery during HIV transcription. The
schematic of the viral genome and primers used in ChIPs are
presented in Figure 5A. Importantly, 50 and 30 primers do not
share any sequences. In the rest of Figure 5, panels B–F contain
ChIPs comparing WT (gray line) to CDK11-depleted (black line)
cells. Panel G contains data from THOC1-depleted cells. Panels
H and I contain PAP ChIPs and western blots for depleted pro-
teins, respectively.
As presented in Figure 5B, CDK11 depletion did not affect
greatly levels of RNAPII at the HIV LTR, the Pol gene or the 30
end. In contrast, levels of Ser2P at the 30 end of HIV gene
decreased 2-fold (Figure 5C). Effects on Ser5P were insignifi-
cant (Figure 5D). As expected, CDK11 depletion also reduced
levels of CDK11 throughout the HIV coding region (Figure 5E).
In these cells, levels of CstF77, an important component of
the CPA, were also reduced, especially at the 30 end (Figure 5F).
Of note, depletion of THOC1 and CDK11 had similar effects on
levels of CDK11 at the HIV gene (compare Figures 5E and 5G).
CDK11 depletion also reduced levels of PAP 4-fold at the 30 end
(Figure 5H). Depletion of THOC1 mirrored that of CDK11 (Fig-
ure S4) except that the knockdown of CDK11 did not reduce
levels of THOC1 at the HIV gene (Figure S4F). Reduced levels
of targeted proteins were confirmed by western blotting (Fig-
ure 5I). Importantly, CDK11 depletion did not affect steady-state
levels of THOC1, CstF77, PAP, or actin proteins (Figure 5I, lanes
1–3). In agreement with our data, levels of Ser2P are known to
increase from the body to 30 end of genes (Davidson et al.,
2014; Eifler et al., 2015). We conclude that TREX/THOC recruits564 Cell Host & Microbe 18, 560–570, November 11, 2015 ª2015 ElsCDK11, which increases levels of Ser2P and CPA factors
toward the HIV 30 end.
Knockdown of CDK11 or THOC1 Increases HIV LTR
Readthrough Transcription in HeLa P4 and J-Lat 9.2
Cells
Since knockdowns of CDK11 and THOC1 affected levels of CPA
factors at the 30 end, we examined this aspect of HIV cotran-
scriptional processing. First, we interrogated the cleavage
reaction. Readthrough transcripts and primers are depicted in
Figure 6A. Note that position 1 corresponds to position 9,530
with respect to the 50 HIV LTR in full-length transcripts of
NL4-3.Luc (Figure 6A). Primers were designed based on HIV
cleavage, which occurs 18 nt downstream of the poly(A) site
(AAUAAA). Readthrough transcription is the ratio of uncleaved
RNA to total RNA 50 to the cleavage site. RT-qPCR with the indi-
cated primers (Fw andRv) demonstrated that levels of uncleaved
HIV RNA increased 20- to 30-fold in CDK11- and THOC1-
depleted cells, respectively (Figure 6B, black bars 2 and 3).
Thus, knockdown of CDK11 reduced levels of total HIV RNA (Fig-
ure 3B) and increased the proportion of extended 30 ends (Fig-
ure 6B). All RT-qPCR samples were normalized toGAPDH levels.
We conclude that CDK11 depletion decreases cleavage of HIV
transcripts.
To confirm these findings, we also examined J-Lat 9.2 cells,
where HIV had integrated into the PP5 gene (Lenasi et al.,
2008). In these cells, HIV is silenced because RNAPII from PP5
gene occludes and terminates in the 50 HIV LTR and the 30 HIV
LTR initiates transcription into the rest of the PP5 gene. This inte-
gration is depicted in Figure 6C. With CDK11 depletion, 8-fold
more transcripts read through the 50 HIV LTR and into the coding
region of the virus (Figure 6D). Again, all RT-qPCR samples were
normalized to GAPDH levels, and the knockdown of CDK11 was
confirmed by western blotting. Thus, CDK11 depletion also in-
creases readthrough transcription of the integrated provirus in
a latently infected T cell line.
We also used a recently published dual fluorescence repoter
assay for readthrough transcription (Ji et al., 2011). In this sys-
tem, the CMV promoter drives the expression of RFP and
EGFP genes, which are separated by poly(A) sites. In addition,
EGFP 30 to the first poly(A) site is translated via an IRES (Fig-
ure S5). With this plasmid target, when CPA occurs normally,
cells turn red. However, when the first poly(A) site is ignored,
then EGFP is also expressed and cells turn yellow. With
CDK11 depletion, 10-fold more 293T cells turned yellow (Fig-
ure S5B and S5C). CDK12 depletion had only a small effect.
Knockdown of CDK12was an important control, as it also affects
30 end processing via the EJC, but mostly of longer genes with
many exons and introns (Blazek et al., 2011). This dual fluores-
cence plasmid target contained no exon junctions. Thus, in all
these situtations, with different poly(A) sites, CDK11 plays a crit-
ical role in CPA.
Levels of CDK11 Affect Polyadenylation and Stability of
HIV Transcripts in HeLa P4 Cells
RNAPII transcription and mRNA processing are coordinated
within the nucleus. CPA occurs cotranscriptionally, suggesting
that RNAPII regulates these events. Indeed, phosphorylation of
the CTD is important for capping, mRNA splicing, and CPAevier Inc.
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Figure 5. Knockdown of CDK11 Decreases Levels of Ser2P and CPA Factors at the HIV 30 End in HeLaP4 Cells
(A) Schematic representation of the NL4-3.Luc. Horizontal lines beneath the gene represent regions amplified by qPCR after ChIPs.
(B–H) Effects of CDK11 depletion and THOC1 depletion (G) on levels of RNAPII, Ser2P, Ser5P, CDK11, CstF77, and PAP at the HIV gene. ChIPs were performed
using indicated antibodies in cells expressing the NL4-3.Luc and treated with siCDK11 or siTHOC1 (black diamonds and lines) and compared to those treated
with siScr RNA (gray circles and lines). Sequences corresponding to the HIV 50 end, Pol, and 30 endwere amplified by qPCR. Values represent percentage of input
normalized to IgG levels. See also Figure S4.
(I) Confirmation of depleted proteins. Presented are western blots of CDK11, THOC1, CstF77, and PAP in cell lysates, where actin represents the loading control.
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Figure 6. Knockdown of CDK11 or THOC1
Increases HIV 30 End Readthrough Tran-
scription in HeLa P4 and J-Lat 9.2 Cells
(A) Schematic representation of primers used for
the HIV 30 end readthrough assay. Note that po-
sition 1 corresponds to position 9,530 from the 50
HIV LTR. Locations of poly(A) and cleavage sites
are depicted by arrows. Fw and Rv are forward
and reverse primers, respectively.
(B) Knockdown of CDK11 or THOC1 increases
readthrough of HIV transcripts. Black bars
represent fold-increased readthrough over WT
cells. Error bars represent the mean ± SE, n = 3.
Western blots of CDK11 and THOC1 with actin
as the loading control are presented below the
bar graph.
(C) Schematic representation of the PP5 gene and
the integrated HIV in J-Lat 9.2 cells. Two different
capped (black circles) transcripts are diagrammed
below the gene, those that terminate in the 50 HIV
LTR and those that readthrough into the viral coding sequences. PCR primers for RT-qPCR are presented below primary transcripts.
(D) CDK11 depletion increases readthrough transcription past the 50 HIV LTR in J-Lat 9.2 cells. Black bar and error bars are as in (B). Western blots of CDK11 with
actin as the loading control are presented below the bar graph.
See also Figure S5.(Barilla` et al., 2001; McCracken et al., 1997). Polyadenylation of
the 30 end of eukaryotic transcripts is associated with several as-
pects of mRNAmetabolism, such asmRNA stability, export, and
translation (Shi and Manley, 2015). To determine if increased
levels of HIV transcripts in Figure 3B could be due to greater sta-
bility and polyadenylation of HIV mRNA species, we measured
their poly(A) tail lengths using the All Tail kit (Biooscientific). Fig-
ure 7A depicts the experimental scheme, where a linker oligonu-
cleotide was ligated to the poly(A) tail at the 30end of viral
transcripts. Next, RNA was reverse transcribed with this linker
primer (Rv) and amplified using an HIV-specific primer (Fw) by
two rounds of PCR. Note that position 1 corresponds to position
9,571 with respect to the 50 HIV LTR in full-length transcripts of
NL4-3.Luc. In addition, the 30 linker measured 20 nt, which in-
creases all PCR products by that amount.
As presented in Figure 7B, lane 3, poly(A) tails of viral tran-
scripts in control samples measured 50 to 150 nt. Cleavage
occurred at position 55, which together with the 20 nt linker mea-
sures 75 nt in the agarose gel (Figure 7B, arrow). This cleavage
site was confirmed by direct sequencing of PCR-amplified
isolated fragments from agarose gels. In cells expressing
f:CDK11, poly(A) tails measured between 225 and 350 nt (Fig-
ure 7B, lane 4). CDK11 depletion not only reduced the general
pool of HIV mRNA but also resulted in insignificant cleavage
and polyadenylation (Figure 7B, lane 2).
To determine if increased length of poly(A) tails in HIV tran-
scripts enhances their stability, we analyzed their degradation
kinetics. We used Actinomycin D mRNA stability assay as
described previously (Zhang et al., 2011). We added Actino-
mycin D to block transcription 24 hr after the transfection, ex-
tracted mRNA at different time points, and measured levels of
HIV transcripts by RT-qPCR. Results were normalized to 18S ri-
bosomal RNA.We found that the half-life of HIVmRNA increased
from 2.5 hr in control to 6 hr in f:CDK11-expressing cells (Fig-
ure 7C). We conclude that by affecting Ser2P near the 30 end,
CDK11 increases the recruitment of CPA factors, cleavage of
primary transcripts, and their polyadenylation. Combined effects566 Cell Host & Microbe 18, 560–570, November 11, 2015 ª2015 Elsof these changes increase the stability of HIV mRNA species,
which results in greater levels of viral gene expression and
replication.
DISCUSSION
In this study, we explored the relationship between CDK11 and
HIV replication. We first defined the CDK11 proteome structur-
ally and functionally and determined that CDK11 is an integral
part of the TREX/THOC, which could inform all previous studies
on this complex. Next, we found that levels of CDK11 directly
affected HIV gene expression and replication. Importantly,
CDK11 functioned as a CTD kinase even in the absence of
CK2. Moreover, although it phosphorylated serines at positions
2 and 5 in the CTD in vitro, ChIPs revealed that CDK11 primarily
affected levels of Ser2P at the HIV 30 end in cells. Increased
levels of Ser2P led to a greater recruitment of CPA factors to
the RNAPII near the HIV 30 end. In CDK11-depleted cells, this
absence resulted in increased readthrough transcription at the
HIV poly(A) site and diminished polyadenylation of all viral tran-
scripts. Different lengths of HIV transcripts also affected their
stability. We conclude that CDK11 is recruited to RNAPII via
TREX/THOC, where it phosphorylates serines at position 2 in
the CTD, which improves 30 end processing of all viral transcripts
and increases HIV replication.
Although we do not know which subunit of TREX/THOC binds
to CycL2:CDK11, this binding appears to be direct and indepen-
dent of RNA. If RNA were involved, CDK11 should have also
coimmunoprecipitated with EJC proteins. Importantly, interac-
tions between CDK11 and TREX/THOC were confirmed with
endogenous proteins and validated by functional studies. More-
over, the overexpression of f:CDK11 increased the luciferase
activity of LTR.Luc as well as NL4-3.Luc. In addition, we found
that levels of Gag polyprotein and its processed subunits were
increased. These findings argue against a major effect of
CDK11 onmRNA splicing. Examination of all three major classes
of HIV transcripts directly confirmed this conclusion. In contrast,evier Inc.
AB
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Figure 7. CDK11 Increases Length of Poly(A)
Tails and Stability of HIV Transcripts in HeLa
P4 Cells
(A) Schematic representation of extreme 30 RACE
using the All Tail kit for poly(A) tail length, with
indicated primer sets. Position 1 was assigned
arbitrarily to the beginning of the forward primer
(Fw). It is 9,571 nucleotides removed from the 50
end of the unsplised (US) genomic NL4.3.Luc
transcript. Note that the ligated primer (in red)
measures 20 nt. Steps in the reaction are depicted
in red. Rv, reverse primer.
(B) Length of HIV poly(A) tails. HIV poly(A) tails in
HeLa P4 cells coexpressing siCDK11, vector, or
f:CDK11 and pNL4-3.Luc were amplified by RT-
qPCR and separated by a 2.5% agarose gel
electophoresis.
(C) CDK11 increases the stability of HIV transcripts.
Measured was the stability of HIV genomic
transcripts in cells coexpressing f:CDK11 and
pNL4-3.Luc. After 24 hr, cells were treated with
Actinomycin D, and RNA was extracted at different
time points. RT-qPCR was performed in duplicate.
Error bars represent mean ± SE, n = 3.CDK11 had major effects on HIV 30 formation. First, depletion of
CDK11 attenuated severely the cleavage of HIV transcripts 30 to
the poly(A) site. Second, HIV transcripts hadmuch longer poly(A)
tails in the presence of f:CDK11. They were also much more
stable. These effects on CPA were due to increased levels of
Ser2P and CPA factors near the 30 end of viral transcripts.
Although we did not examine all CstF or CPSF proteins, they
and PAP coaggregate and accumulate near the poly(A) site
and are required for efficient termination of transcription.
Our findings build on the work of two previous reports on
CDK11 and HIV replication. In one study, the CDK11 depletion
greatly attenuated HIV replication (Yu et al., 2008). Another study
found that the overexpression of CDK11 could also restrict
the infection by a pseudotyped, puromycin-resistant HIV in
colony-forming assays (Valente et al., 2009). As mentioned pre-
viously, CDK11 has three isoforms: p110, p58, and p46. The
apoptosis-inducing p46 isoform represents a caspase cleavage
product of p110 (Mikolajczyk and Nelson, 2004). Since puromy-
cin activates caspases (Koh et al., 2011; Naarmann-de Vries
et al., 2013), such treatment of cells overexpressing CDK11
p110 (Valente et al., 2009) could have increased levels of p46,
thus resulting in fewer HIV colonies. Indeed, we failed to estab-
lish stable f:CDK11-expressing cell lines in the presence of puro-
mycin (data not presented). Importantly, we did not observe any
diminution of HIV gene expression or replication with our overex-
pression of f:CDK11 in our transient assays. Moreover, we deter-
mined the mechanism by which CDK11 affected these changes
in HIV gene expression. Another important observation concerns
physiological levels of CDK11 in human cells. In all transformed
cell lines, be they of lymphoid or epithelial origin, levels of
CycL2:CDK11 are high. In contrast, they are vanishingly low in
resting CD4+ T cells (data not presented). This observation pre-
vented us from repeating our studies in primary cells. Neverthe-
less, our findings and those already published onCDK11 andHIV
were obtained in cells that are fully permissive for HIV replication.
Together with observed low levels of P-TEFb in resting lympho-
cytes, the lack of these additional transcriptional CDKs couldCell Host &represent major obstacles to the reactivation of HIV in latently in-
fected cells in humans.
Another important issue concerns the uniqueness and redun-
dancy of CTD kinases. Thus far, CDK7, CDK8, CDK9, CDK11,
CDK12, and CDK13 can all phosphorylate the CTD of RNAPII.
However, some, like CycH:CDK7, prefer serines at position 5,
whereas P-TEFb, CDK11, and CycK complexes target serines
at position 2 in cells. For this differential phosphorylation, it is
possible that after serines at positions 5 and/or 7 had been phos-
phorylated by CDK7, the CDKs that are recruited later target the
now better-exposed serines at position 2. Of interest, CDK11,
CDK12, and CDK13 associate with RNAPII during elongation.
There is also a hierarchy of importance, such that most if not
all promoters require P-TEFb for transition from initiation to elon-
gation of transcription. CDK12 affects only a small subset of
acute response and longer genes, e.g., those that code for
DNA damage response factors. CDK11 appears to have a
broader range, especially since TREX/THOC is recruited to
many coding genes. That these kinases are not redundant is
also apparent from studies of HIV. Thus, Tat augments the ability
of CycH:CDK7 to cap HIV transcripts (Zhou et al., 2003). P-TEFb
is required for Tat transactivation and transition from initiation to
elongation of viral transcription (Peterlin and Price, 2006). CDK13
affects HIV splicing, such that its overexpression favors multiply
spliced rather than genomic RNA species (Berro et al., 2008).
CDK11 now takes its place in HIV 30 end formation. How these
transcriptional CDKs imprint directions on the CTD, i.e., which
heptapeptide repeats are targeted and when remain to be
explored. Nevertheless, the CTD appears to be the central pro-
cessing unit of transcription and cotranscriptional processing
of eukaryotic and HIV genes.
CDK11 also plays an important role for other genes and ap-
pears to be the critical CTD kinase for their 30 end formation. In
addition to our work, in one study, where levels of only P-TEFb
were increased due to the disruption of the 7SK snRNP,
RNAPII elongated efficiently, but did not terminate and read
through megabases of genomic DNA (Castelo-Branco et al.,Microbe 18, 560–570, November 11, 2015 ª2015 Elsevier Inc. 567
2013). In this context, levels of other transcriptional CDKs or
CDK11 must have been insufficient for proper cotranscriptional
processing of these genes. Similarly, in our study, CDK11 deple-
tion led to increased readthrough transcription of a transcription-
ally interfered HIV, which had integrated into an active cell host
gene in the sense orientation. Indeed, most HIV integrates into
actively transcribed genes (Schro¨der et al., 2002). Thus, during
attempts at HIV reactivation from latency, if P-TEFb levels in-
crease but those of CDK11 lag behind, many apparent HIV-spe-
cific transcripts will represent readthrough transcripts from cell
host genes. Thus, RNA levels would not translate to amounts
of HIV proteins and numbers of new viral particles. This consid-
eration is of importance in all studies of HIV reactivation from
latency and attempts at purging the viral reservoir in infected
individuals.
Our study also addresses the function of TREX/THOC, which
is a highly conserved multimeric complex from yeast to humans
and is required for mRNP biogenesis (Luna et al., 2012). This
complex connects transcription elongation with 30 end mRNA
processing (Aguilera, 2005). For example, one member of
the THO subcomplex, THOC5, is necessary for recruiting
CPSF100 to immediate early genes (Tran et al., 2014). Thus,
CPA of newly synthesized mRNA at 30 end ensures that nascent
RNA is protected from degradation (Proudfoot, 2011). Our
studies address these processes and connect TREX/THOC,
CDK11, and the CTD of RNAPII in transcription. Finally, CDK11
also plays an important role in cancer. Its expression is high
and critical for growth and proliferation of breast cancer, osteo-
sarcoma, and liposarcoma (Duan et al., 2012; Jia et al., 2014). In
these cells, the depletion of CDK11 resulted in the loss of cancer
cell viability and led to their apoptosis (Kren et al., 2015). Taken
together, these findings suggest that CDK11 is a promising
target for therapeutic drug development to combat HIV/AIDS
and cancer.
EXPERIMENTAL PROCEDURES
Plasmids
Plasmids were as follows: pUHD10-3CDK11FLAG p110 (f:CDK11) (Jill M.
Lahti), PCMV (Bin Tian), NL4-3Luc (AIDS Reagents Program, #3418), LTR.Luc
(Bartholomeeusen et al., 2013), CMV.luc, c-Jun.Luc, MCK.Luc, EIAV.Luc,
and RSV.Luc (Clarke et al., 1998; Kowalska et al., 2012; Nojima et al., 2008;
Taube et al., 2000; Vasanwala et al., 2002), and pcDNA3.1 (V790-20,
Invitrogen).
Antibodies
Antibodies were as follows: anti-CDK11, SAP18, SCAMP2, THOC1, THOC5,
UAP56, THOC7 (Abcam, 19393, 31748, 154181, 487, 47955, 86070, 72295),
anti-CDK11, CycL1, CycL2, IgG, eiF4A3, RBM8A (Bethyl, A300-310A, A302-
058A, A301-677A, MI10-102, A302-981A, A301-033A), anti-THOC6, THOC1,
CK2, RNAPII N20, PAP (Santa Cruz, 101177, 136426, 6479, 899, 32915),
anti-Ser2P, Ser5P (Covance, H5, H14), anti-FLAG, HA, IgM, IgG (Sigma-
Aldrich, F3165, F7425, H3663, H6908, A4540, A5420), peroxidase-conjugated
monoclonal mouse anti-IgG (Jackson ImmunoResearch, 211-032-171, 115-
035-174), and anti-CstF77 (David Bentley).
Transfections, Luciferase Reporter Assays, and p24 CA ELISA
293T and HeLa P4 were transfected with 0.1 mg of NL4-3.Luc or LTR.Luc plas-
mids with 2 mg of f:CDK11 or empty plasmid vector in 12-well plates using
X-TremeGENE (Roche) reagent following the manufacturer’s protocol. Trans-
fections of Jurkat and J-Lat 9.2 cells were carried out using the Neon Transfec-
tion System (ThermoFisher Scientific) at 1,150 V for 30ms with two pulses with568 Cell Host & Microbe 18, 560–570, November 11, 2015 ª2015 Els5 mg of NL4-3.Luc or LTR.Luc plasmids with 10 mg of f:CDK11 or empty
plasmid vector. After 4872 hr, cells were lysed, and a standard luciferase
(Pak et al., 2011) assay was performed. Supernatants from cells cotransfected
with NL4-3.Luc and f:CDK11 or empty plasmid vector were collected and
passed through a 0.45 mm filter. Supernatants were diluted for standard ELISA
protocol. HIV p24 CA ELISA kit (Perkin Elmer, NEK050B) was used in dupli-
cates to determine levels of new viral particles in supernatants following the
manufacturer’s protocol. Knockdown experiments with siRNA (IDT) were per-
formed using RNAiMAx (Invitrogen) or Pepmute (SignaGen) reagents to trans-
fect 293T and HeLa P4 cells while Jurkat were transfected using the Neon
Transfection System as described above. After 24 hr, 0.1 mg of NL4-3.Luc
and 2 mg of f:CDK11 or empty plasmid vector were transfected in 12-well
plates. After 48 hr, cells were lysed and processed for luciferase assay.
Immunoprecipitation and Western Blotting
For immunoprecipitation, f:CDK11 was overexpressed in 293T cells. Cells
were lysed in lysis buffer (HEPES [pH 7.9], 100 mM KCl, 0.2 mM EDTA,
5 mM b-mercaptoethanol, 0.1% Nonidet P-40, 10% glycerol, and protease in-
hibitors [Roche Molecular Biochemicals]), sonicated, and cleared by centrifu-
gation at 20,000 g for 15 min at 4C. Washed Sepharose 4B beads (Invitrogen)
were incubated with lysates for 1 hr at 4C. Beads were then discarded, and
lysates were incubated overnight with rabbit anti-FLAG antibodies, protein-
specific or rabbit IgG antibodies at 4C. Prewashed protein G-conjugated Se-
pharose 4B beads (Invitrogen) were added to the lysate, and the lysate-bead
mixtures were incubated for 1 hr at 4C. Beads-antibody conjugates were
washed five times in lysis buffer and then heated at 95C for 5 min with
SDS-PAGE sample buffer (Bio-Rad). Collected samples were processed for
gel electrophoresis. For western blotting, samples were run on 4%–18%
SDS PAGE, transferred to nitrocellulose membranes, probed with specific pri-
mary antibodies, washed five times, and incubated with peroxidase-conju-
gated or IRDye fluorescent secondary antibodies (Li-Cor). Membranes were
visualized using the Odyssey Fc imaging system (Li-Cor).
RT-qPCR
293T, HeLa P4, and Jurkat cells were cotransfected as described above. After
48 hr, RNA was extracted using TRIZOL reagent (Invitrogen) and treated with
Turbo DNase (Ambion). RNA samples were reverse transcribed using the Su-
perscript III First Strand System (Invitrogen) with the oligo dT primer, random
hexamers, or gene-specific primers to produce cDNA. Primers used to detect
different mRNA species are described previously (Jablonski andCaputi, 2009).
qPCR was performed using SensiFAST SYBR Lo-ROX kit (Bioline) following
the manufacturer’s protocol. Results were normalized to GAPDH.
Chromatin Immunoprecipitation Assays
CDK11 or THOC1 was depleted in 293T cells or HeLa P4 cells by transfection
of siRNA as described above. After 24 hr, siRNA-treated cells were transfected
with NL4-3.Luc. After 48 hr, chromatin was extracted from the cells as
described by Carey and colleagues in Cold Spring Harbor Protocols (Carey
et al., 2009) with modifications, where the total sonication time was increased
to 5 min and performed in ice-cold ethanol or an ice-salt slurry.
GST-CTD Purification and Phosphorylation Assay
GST-CTD purification and phosphorylation assays were performed as
described previously (Czudnochowski et al., 2012).
Mass Spectrometry
Mass spectrometry was performed essentially as described previously for
CDK12 (Eifler et al., 2015).
Determination of Poly(A) Tail Length and 30 End Formation
Poly(A) tail was measured using the ALL-TAIL kit (Biooscientific). Briefly, HeLa
P4 cells coexpressed 0.1 mg of NL4-3.Luc and 2 mg of f:CDK11 or empty
plasmid vector in 12-well plates. After 48 hr, RNA was extracted using TRIZOL
reagent (Invitrogen) and 1 mg RNA was treated with Turbo DNase (Ambion).
Isolated RNAwas ligated to the AIR Adenylated Linker C and then reverse tran-
scribed with Linker C universal primer. Primers are Fw (GGCAGCTGTA
GATCTTAGCC) and Universal Linker C, Rv from ALL-TAIL kit (Biooscientific).
Poly(A) tails (or 30 end) were resolved on 2.5%agarose gels, stained with SYBRevier Inc.
Gold nucleic acid gel stain (Molecular probe, S11494) and visualized using
Odyssey Fc imaging system.
Readthrough Transcription
Readthrough transcription assays were performed as described (Eifler et al.,
2015). cDNA was synthesized using random hexamers and subjected to
qPCR analysis with primers Fw (TAGTGTGTGCCCGTCTGTT) and Rv (CCTC
CTGGGTGCTAGAGATTT). For J-Lat 9.2 cells, primers were Fw, (GGAAAAGT
TATCTTGGTAGC) and Rv (GTTTGTATGTCTGTTGCTATT).
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